Ռանիտիդին

main_info

  • trade_name:
  • Ռանիտիդին
  • dosage:
  • 150մգ(10/1x10/) և (20/2x10/) բլիստերում
  • pharmaceutical_form:
  • դեղահատեր թաղանթապատ
  • prescription_type:
  • Դեղատոմսով
  • medicine_domain:
  • Human
  • medicine_type:
  • Allopathic

documents

localization

  • country:
  • Ռանիտիդին
    አርሜኒያ
  • language:
  • አማርኛ

other_info

status

  • source:
  • Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում - Armenia
  • last_update:
  • 31-05-2018

12-4-2019

EFSA Workshop on in vitro comparative metabolism studies in regulatory pesticide risk assessment

EFSA Workshop on in vitro comparative metabolism studies in regulatory pesticide risk assessment

Published on: Thu, 11 Apr 2019 The European Union (EU) pesticides Regulation established that in vitro comparative metabolism studies shall be performed. At present an Organisation for Economic Co‐operation and Development (OECD) test guideline for this kind of studies is not available. The European Food Safety Authority (EFSA) Workshop on in vitro comparative metabolism studies in regulatory pesticide risk assessment discussed the use of these studies to identify human metabolites and to support the as...

Europe - EFSA - European Food Safety Authority EFSA Journal

27-3-2019

Cambridge Elevating Inc. recalls select Elmira, Heritage and Hybrid Residential Elevators

Cambridge Elevating Inc. recalls select Elmira, Heritage and Hybrid Residential Elevators

The microprocessor chip used to control the operation of the elevator may become corrupt. If this data becomes corrupted, the landing door may unlock when the elevator cab is not present, exposing an empty elevator shaft, posing a fall hazard.

Health Canada

19-3-2019

Minister Bruins over no deal Brexit: Desnoods ontheffing voor medisch hulpmiddel met Brits certificaat

Minister Bruins over no deal Brexit: Desnoods ontheffing voor medisch hulpmiddel met Brits certificaat

Bij een eventueel vertrek van het Verenigd Koninkrijk uit de Europese Unie zonder terugtrekkingsakkoord (no deal scenario) is alles erop gericht dat de zorg in Nederland daar zo min mogelijk hinder van ondervindt. Het waarborgen van de continuïteit van de zorg staat voorop, schrijft minister Bruno Bruins (Medische Zorg) vandaag in een brief aan de Tweede Kamer. Bruins maant producenten van medische hulpmiddelen met een Brits CE-certificaat opnieuw tot haast bij het omzetten van de registratie. In uiterst...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

8-3-2019

Safety assessment of the process ‘Jász‐Plasztik’, based on Vacurema Prime technology, used to recycle post‐consumer PET into food contact materials

Safety assessment of the process ‘Jász‐Plasztik’, based on Vacurema Prime technology, used to recycle post‐consumer PET into food contact materials

Published on: Thu, 07 Mar 2019 The EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP Panel) assessed the safety of the recycling process Jász‐Plasztik (EU register number RECYC0157). The input are hot caustic washed and dried poly(ethylene terephthalate) (PET) flakes originating from collected post‐consumer PET containers and containing no more than 5% PET from non‐food applications. They are heated in a batch reactor under vacuum and then heated in a continuous reactor under vacuum...

Europe - EFSA - European Food Safety Authority EFSA Journal

25-1-2019


Agenda - Industry stakeholder meeting on Brexit and operation of the centralised procedure for human and veterinary medicine products

Agenda - Industry stakeholder meeting on Brexit and operation of the centralised procedure for human and veterinary medicine products

Agenda - Industry stakeholder meeting on Brexit and operation of the centralised procedure for human and veterinary medicine products

Europe - EMA - European Medicines Agency

25-1-2019


Industry stakeholder meeting on Brexit and operation of the centralised procedure for human and veterinary medicine products, European Medicines Agency, London, UK, from 28/01/2019 to 28/01/2019

Industry stakeholder meeting on Brexit and operation of the centralised procedure for human and veterinary medicine products, European Medicines Agency, London, UK, from 28/01/2019 to 28/01/2019

Industry stakeholder meeting on Brexit and operation of the centralised procedure for human and veterinary medicine products, European Medicines Agency, London, UK, from 28/01/2019 to 28/01/2019

Europe - EMA - European Medicines Agency

25-1-2019

Husqvarna recalls certain Husqvarna Brand Walk Behind Mowers

Husqvarna recalls certain Husqvarna Brand Walk Behind Mowers

A short circuit could occur in the equipment electronics during use or storage of these lawnmowers. If the operator does not follow the operating instructions after an unsuccessful restart attempt, the short circuit in the motor control unit may result in increased electrical currents flowing into a nearby component. This poses a risk of the component to overheat or burn, or cause a potential fire.

Health Canada

22-12-2018

Bruno Bruins investeert in veiligheid van implantaten

Bruno Bruins investeert in veiligheid van implantaten

Voor het plaatsen van een implantaat bestaat vaak een medische noodzaak, maar niet altijd. Zoals bij alle medische ingrepen moeten de voordelen en de risico’s worden afgewogen. Het is cruciaal dat artsen over de risico’s van implantaten in gesprek gaan met de patiënt, zodat ze samen kunnen beslissen over de beste behandeling. Daarvoor is de juiste informatie nodig. Patiënten moeten weten waarom de plaatsing van een implantaat nodig is, maar ook welke risico’s (de operatie met) het implantaat met zich mee...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

15-12-2018

Annual report of the Scientific Network on Microbiological Risk Assessment 2018

Annual report of the Scientific Network on Microbiological Risk Assessment 2018

Published on: Fri, 14 Dec 2018 Among the tasks of EFSA, according to its founding regulation (Regulation (EC) No 178/2002), there is the establishment of a system of Networks of organisations operating in the fields within EFSA's mission, the objective being to facilitate a scientific cooperation framework by the coordination of activities, the exchange of information, the development and implementation of joint projects, the exchange of expertise and best practices. Additionally, the EFSA Science Strat...

Europe - EFSA - European Food Safety Authority Publications

23-10-2018

FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids

FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids

FDA warns website networks as part of global crack down for selling illegal pharmaceuticals

FDA - U.S. Food and Drug Administration

23-10-2018

Operation Pangea XI reinforces the dangers of buying unauthorized health products online

Operation Pangea XI reinforces the dangers of buying unauthorized health products online

October 23, 2018 For immediate release

Health Canada

28-9-2018

Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label

Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label

Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc., is voluntarily recalling two lots of Robaxin® (methocarbamol tablets, USP) 750mg Tablets 100 Count Bottle pack to the consumer level. The products have been found to have incorrect daily dosing information on the label due to a labeling error which misstates the daily dose as "two to four tablets four times daily" rather than the correct dosage of "two tablets three times daily." (see pic...

FDA - U.S. Food and Drug Administration

26-9-2018

Technical Report on the notification of syrup from Sorghum bicolor (L.) Moench as a traditional food from a third country pursuant to Article 14 of Regulation (EU) 2015/2283

Technical Report on the notification of syrup from Sorghum bicolor (L.) Moench as a traditional food from a third country pursuant to Article 14 of Regulation (EU) 2015/2283

Published on: Tue, 25 Sep 2018 00:00:00 +0200 Abstract Following a notification from Sorghum Zrt., submitted to the European Commission under Article 14 of Regulation (EU) 2015/2283 to place on the market syrup from Sorghum bicolor (L.) Moench as a traditional food from a third country (TF), and in line with Article 15(2) of that Regulation, EFSA was asked by the European Commission whether there are duly reasoned safety objections to the placing on the market of the TF within the European Union. The ap...

Europe - EFSA - European Food Safety Authority Publications

30-8-2018

Grant agreement for piloting the Framework Partnership Agreement between the National data provider organisations in Cyprus and EFSA – Final report

Grant agreement for piloting the Framework Partnership Agreement between the National data provider organisations in Cyprus and EFSA – Final report

Published on: Tue, 07 Aug 2018 00:00:00 +0200 Cyprus alongside with another 4 countries has participated successfully in the Grant Agreement GP/EFSA/DATA/2016/01‐GA 02, entitled: “Strategic Partnership with Cyprus on Data Quality”. The project was co‐financed by EFSA, aiming to help both EFSA and data providers from Member States to possess data of high quality in a quantitatively manageable way. The main objective of the grant agreement was the establishment of the data governance, coordination and imp...

Europe - EFSA - European Food Safety Authority Publications

30-8-2018

Grant agreement for piloting the Framework Partnership Agreement between the National data provider organisations in Denmark and EFSA – Final report

Grant agreement for piloting the Framework Partnership Agreement between the National data provider organisations in Denmark and EFSA – Final report

Published on: Tue, 07 Aug 2018 00:00:00 +0200 During the project seven standard operating procedures (SOP) were developed for the four data domains (zoonoses, chemical contaminant, pesticide residues and veterinary medical products residues). The SOPs describe 1) How the national governance of risk assessment data is organised, 2) how data are collected and validated before delivering to EFSA covering all four domains, 3) How data is transferred to EFSA, 4) how to respond to EFSA request for clarificati...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Safety assessment of the process ‘General Plastic’, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials

Safety assessment of the process ‘General Plastic’, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials

Published on: Fri, 10 Aug 2018 00:00:00 +0200 This scientific opinion of the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF Panel) deals with the safety evaluation of the recycling process General Plastic (EU register No RECYC153), which is based on the Starlinger Decon technology. The decontamination efficiency of the process was demonstrated by a challenge test. The input of this process is hot caustic washed and dried poly(ethylene terephthalate) (PET) flakes orig...

Europe - EFSA - European Food Safety Authority Publications

12-7-2018

Plant health and citizen science: ANSES takes part in an operation to detect giant ragweed

Plant health and citizen science: ANSES takes part in an operation to detect giant ragweed

ANSES is taking part in a citizen observation mission targeting the giant ragweed plant (Ambrosia trifida) in partnership with the Tela Botanica Association and the Ragweed Observatory. Ambrosia trifidais an invasive alien species posing a threat to health and agriculture, because it releases pollen that is highly allergenic to humans and colonises crops leading to yield losses.

France - Agence Nationale du Médicament Vétérinaire

2-7-2018

Blissful Remedies Issues Voluntary Nationwide Recall of Certain Kratom Powder Capsule

Blissful Remedies Issues Voluntary Nationwide Recall of Certain Kratom Powder Capsule

Blissful Remedies., is voluntarily recalling only Lot No.: 112710 with expiration 03/2019 found embedded on the top of package of kratom ( mitragyn a speciosa) powder products, it manufactured, processed, packed, and/or held, between “March 1, 2018” to “April 30, 2018” to the consumer level. The products have been found by the U.S. Food and Drug Administration (“FDA”) via sample testing to have salmonella contamination. Blissful Remedies has not received reports of adverse events related to this recall. ...

FDA - U.S. Food and Drug Administration

29-6-2018

Pending EC decision:  Nerlynx, neratinib, Opinion date: 28-Jun-2018

Pending EC decision: Nerlynx, neratinib, Opinion date: 28-Jun-2018

Europe - EMA - European Medicines Agency

22-6-2018

Kratom (mitragyna speciosa) Powder Products by Gaia Ethnobotanical: Recall - Due to Potential Salmonella Contamination

Kratom (mitragyna speciosa) Powder Products by Gaia Ethnobotanical: Recall - Due to Potential Salmonella Contamination

The products have been found by the FDA via sample testing and finding to have salmonella contamination. In lieu of such FDA findings the company has implemented standard operating procedures and sterilization processes in accordance to FDA guidelines

FDA - U.S. Food and Drug Administration

21-6-2018

Gaia Ethnobotanical, LLC., Voluntarily Recalls Kratom Products Due to Potential Salmonella Contamination

Gaia Ethnobotanical, LLC., Voluntarily Recalls Kratom Products Due to Potential Salmonella Contamination

Gaia Ethnobotanical, LLC., is voluntarily recalling all kratom (mitragyna speciosa) powder products, with Lot No.: 0102031800 it manufactured, processed, packed, and/or held, between March 18, 2018 to March 30, 2018 to the consumer level. The products have been found by the U.S. Food and Drug Administration (“FDA”) via sample testing and finding to have salmonella contamination. In lieu of such FDA findings the company has implemented standard operating procedures and sterilization processes in accordanc...

FDA - U.S. Food and Drug Administration

18-6-2018

June 15, 2018: Theranos Founder and Former Chief Operating Officer Charged in Alleged Wire Fraud Schemes

June 15, 2018: Theranos Founder and Former Chief Operating Officer Charged in Alleged Wire Fraud Schemes

June 15, 2018: Theranos Founder and Former Chief Operating Officer Charged in Alleged Wire Fraud Schemes

FDA - U.S. Food and Drug Administration

6-6-2018

CARDIOSAVE Hybrid Intra-aortic Balloon Pump by Maquet Datascope Corp.: Class I Recall - Due to Fluid Ingress that May Affect Device Operation and Interrupt or Delay Therapy

CARDIOSAVE Hybrid Intra-aortic Balloon Pump by Maquet Datascope Corp.: Class I Recall - Due to Fluid Ingress that May Affect Device Operation and Interrupt or Delay Therapy

Maquet Datascope Corp. is recalling the IABP due to a design issue that allows fluid (such as saline) to seep into the device. The fluid can cause corrosion of internal components such as the electronic circuit boards, and lead to device malfunction (e.g., sudden stops) which can cause a delay or interruption in therapy. Device failure may result in immediate and serious adverse health consequences, including death.

FDA - U.S. Food and Drug Administration

5-6-2018

FDA takes action against 53 websites marketing unapproved opioids as part of a comprehensive effort to target illegal online sales

FDA takes action against 53 websites marketing unapproved opioids as part of a comprehensive effort to target illegal online sales

FDA announced that it has warned nine online networks, operating a total of 53 websites, that they must stop illegally marketing potentially dangerous, unapproved and misbranded versions of opioid medications, including tramadol and oxycodone.

FDA - U.S. Food and Drug Administration

9-5-2018

Fabius Anesthesia Machines by Dräger Medical: Class I Recall - Due to Production Step Error

Fabius Anesthesia Machines by Dräger Medical: Class I Recall - Due to Production Step Error

Dräger Medical is recalling the Fabius Anesthesia machines due to excessive oil that was not removed at the time of production. Such excess oil may interfere with the position detector of the ventilation motor during operation and may cause ventilation to fail. A halt in ventilation may lead to serious adverse health consequences, including patient injury or death.

FDA - U.S. Food and Drug Administration

25-9-2017

Global operation against illegal medicines

Global operation against illegal medicines

A global operation against illegal medicines has been completed. 123 countries participated, and the operation resulted in 354 arrests or further investigations and the suspension of more than 3,500 websites.

Danish Medicines Agency

10-6-2016

Operation targets illegal medicines

Operation targets illegal medicines

Global medicine operation just completed. Operation Pangea resulted in 393 arrests and the suspension of more than 4,900 websites.

Danish Medicines Agency

19-6-2015

Global operation against illicit medicines completed

Global operation against illicit medicines completed

A global medicine operation results in 156 arrests and shutdown of more than 2,400 websites.

Danish Medicines Agency

28-5-2014

More than 10,000 websites shut down in global operation

More than 10,000 websites shut down in global operation

The recent global Operation PANGEA VII resulted in the shutdown of more than 10,000 websites. The operation focused on combating online sale of counterfeit medicines and making consumers aware that they need to take care of themselves when buying medicines online. Globally, the operation led to 237 arrests, some 540,000 parcels were inspected and over 9.4 million units containing potentially life-threatening medicines were seized – worth an estimated value of more than USD 35 million. More than 10,000 we...

Danish Medicines Agency

29-3-2019

Nerlynx (Puma Biotechnology B.V.)

Nerlynx (Puma Biotechnology B.V.)

Nerlynx (Active substance: neratinib) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2019)2579 of Fri, 29 Mar 2019 European Medicines Agency (EMA) procedure number: EMEA/H/C/4030/T/01

Europe -DG Health and Food Safety

11-3-2019


EMA now operating from Amsterdam

EMA now operating from Amsterdam

EMA now operating from Amsterdam

Europe - EMA - European Medicines Agency

14-12-2018

Review of the Narcotic Drugs Act 1967

Review of the Narcotic Drugs Act 1967

Professor John McMillan AO appointed to review and report on the operation of the Narcotic Drugs Act 1967

Therapeutic Goods Administration - Australia

29-11-2018

Company will pay over $25,000 in fines for alleged importation of unapproved therapeutic goods

Company will pay over $25,000 in fines for alleged importation of unapproved therapeutic goods

Operation Antlia targeted the illegal use of therapeutic goods in the cosmetics industry

Therapeutic Goods Administration - Australia

4-9-2018

Nerlynx (Puma Biotechnology, Ltd.)

Nerlynx (Puma Biotechnology, Ltd.)

Nerlynx (Active substance: neratinib) - Centralised - Authorisation - Commission Decision (2018)5864 of Tue, 04 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4030

Europe -DG Health and Food Safety